MktsMarkets

MaxCyte, Inc.
NASDAQ: MXCTKey statistics
MXCT News
Stories mentioning MXCT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 4,501 | 4,787 | 4,603 | 5,824 | 5,743 | 6,054 | 5,612 | 4,965 |
| Cost of Goods Sold | 1,569 | 1,610 | 1,596 | 1,519 | 1,497 | 2,281 | 1,928 | 1,488 |
| Gross Profit | 8,082 | 5,690 | 5,233 | 6,988 | 8,893 | 6,411 | 6,236 | 8,941 |
| Operating Expenses | ||||||||
| Research & Development | 3,857 | 3,335 | 5,316 | 6,269 | 5,903 | 4,614 | 5,316 | 5,619 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 14,267 | 16,916 | 19,382 | 21,215 | 21,188 | 19,312 | 20,289 | 20,909 |
| Operating Income (Loss) | (6,185) | (11,226) | (14,149) | (14,227) | (12,295) | (12,901) | (14,053) | (11,968) |
| Interest Income | 1,435 | 1,630 | 1,733 | 1,870 | 2,034 | 2,304 | 2,496 | 2,593 |
| Interest Expense | ||||||||
| Other Expense | 1,435 | 1,630 | 1,733 | 1,870 | 2,034 | 2,304 | 2,496 | 2,593 |
| Pretax Income | (4,750) | (9,596) | (12,416) | (12,357) | (10,261) | (10,597) | (11,557) | (9,375) |
| Tax Provision | ||||||||
| Net Income (Loss) | (4,750) | (9,596) | (12,416) | (12,357) | (10,261) | (10,597) | (11,557) | (9,375) |
| Earnings Per Share (Basic) | (0.04) | (0.09) | (0.12) | (0.12) | (0.10) | (0.10) | (0.11) | (0.09) |
| Earnings Per Share (Diluted) | (0.04) | (0.09) | (0.12) | (0.12) | (0.10) | (0.10) | (0.11) | (0.09) |
| Weighted Average Shares Outstanding (Basic) | 106,875 | 106,428 | 106,613 | 106,404 | 105,950 | 104,849 | 105,110 | 104,639 |
| Weighted Average Shares Outstanding (Diluted) | 106,875 | 106,428 | 106,613 | 106,404 | 105,950 | 104,849 | 105,110 | 104,639 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MXCT
MaxCyte, Inc. (NASDAQ: MXCT) is a stock listed on the Nasdaq Stock Market under the ticker symbol MXCT. It last traded at $1.43 (Oct 20, 2026, 4:00 PM ET), up 10.0% on the day. That gives MaxCyte a market capitalisation of $136.7M.
Over the past 52 weeks MXCT has traded between $0.6400 and $1.80.
Revenue for the quarter ended Mar 31, 2026 was $4.5M; a net loss of $4.8M. Revenue was down 21.6% from $5.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $4.5M | -$4.8M | -105.5% |
| Dec 31, 2025 | $4.8M | -$9.6M | -200.5% |
| Sep 30, 2025 | $4.6M | -$12.4M | -269.7% |
| Jun 30, 2025 | $5.8M | -$12.4M | -212.2% |
From MaxCyte’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…